文献速递血液净化与透析

接受维持性透析成人随机对照试验中的性与社会性别:一项Meta流行病学研究

Sex and Gender in Randomized Controlled Trials of Adults Receiving Maintenance Dialysis: A Meta-epidemiologic Study.
PubMed 文献 · Am J Kidney Dis · 2022-12-16

该Meta流行病学研究分析了2000至2020年间高影响力期刊发表的561项维持性透析随机对照试验,描述性与社会性别概念的纳入情况。女性或女性参与者平均比例为0.40±0.13,39.0%的试验报告了生理性别,26.6%报告了社会性别。除地区外,无其他试验特征与女性比例独立相关。

要点

  • 561项透析随机对照试验中,女性或女性参与者平均比例为0.40±0.13。
  • 39.0%的试验报告了生理性别,26.6%报告了社会性别,仅15.5%同时提及女性和女性。
  • 仅2.7%的试验将性与/或社会性别作为纳入标准,26.6%作为排除标准。

核心结论

  • 透析随机对照试验在性与社会性别方面对一般透析人群具有代表性,但很少同时报告两者,且常未将任一纳入报告或分析。

研究设计与样本

  • Meta流行病学研究,纳入2000至2020年发表于高影响力期刊的561项维持性透析随机对照试验。
  • 数据提取由两人重复进行,分歧由第三位审阅者解决。
  • 采用Meta回归分析识别与女性或女性参与者比例独立相关的试验特征。

主要发现

  • 纳入的561项随机对照试验中,69.7%为平行设计,28.0%为交叉设计;80.6%在血液透析人群中进行。
  • 25%的试验将干预与安慰剂对照,25%与常规治疗对照,50%与积极替代治疗对照;37.6%为设盲试验。
  • 试验样本量中位数为60(IQR,26-151)例,随访时间中位数为154(IQR,42-365)天。
  • 女性或女性参与者平均比例为0.40±0.13;39.0%的试验报告了生理性别,26.6%报告了社会性别,56.2%称参与者为女性,25.3%称为妇女,15.5%同时称为女性和妇女。
  • 除地区外,无其他试验特征与女性或女性参与者比例相关(亚洲β=0.062,95%CI 0.007-0.117);2.7%的试验将性与/或社会性别作为纳入标准,26.6%作为排除标准,4.5%用于随机化,4.8%用于亚组分析,15.7%用于协变量调整。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 仅研究了高影响力期刊文章。
  • 纳入研究缺乏儿科试验、涉及慢性肾脏病或肾移植的试验以及来自非洲的任何试验,其他地区代表性不足。
  • 存在缺失数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE & OBJECTIVE: How sex and gender concepts are incorporated into randomized controlled trials (RCTs) in adults with kidney failure receiving maintenance dialysis is largely unknown. We describe these practices in published journal articles as well as investigate the proportion of women and female participants in these studies. STUDY DESIGN: Meta-epidemiologic study. SETTING & STUDY POPULATIONS: RCTs in maintenance dialysis. SELECTION CRITERIA FOR STUDIES: Trials published in high-impact journals in 2000-2020. DATA EXTRACTION: Implemented in duplicate with conflicts resolved by a third reviewer. ANALYTICAL APPROACH: Meta-regression was performed to identify trial characteristics independently associated with the proportion of women and female participants. RESULTS: Among 561 included RCTs, 69.7% were parallel and 28.0% were crossover in design; 80.6% were conducted in the hemodialysis population; and 25% of trials compared the treatment of interest with a placebo arm, 25% with a usual care treatment arm, and 50% with an active alternative therapy arm. Of the RCTS, 37.6% were masked. The median size was 60 (IQR, 26-151) participants, and the median follow-up period was 154 (IQR, 42-365) days. The mean proportion of women or female participants was 0.40±0.13 (SD): 39.0% of trials reported sex, and 26.6% reported the gender of the participants. Also, 56.2% referred to participants as females, 25.3% referred to participants as women, and 15.5% referred to both females and women. No trial characteristic other than region (β of 0.062 [95% CI, 0.007-0.117] for Asia) was associated with the proportion of women or female participants. Considering trial design and conduct, 2.7% of trials used sex and/or gender as an inclusion criterion, 26.6% as an exclusion criterion, 4.5% for randomization, 4.8% for subgroup analyses, and 15.7% for covariate adjustment. LIMITATIONS: Only high-impact journal articles were studied; and the included studies lacked pediatric trials, those addressing chronic kidney disease or kidney transplantation, any trials from Africa and underrepresentation of other regions, and missing data. CONCLUSIONS: RCTs in dialysis are representative of the general dialysis population with regard to sex and gender but they uncommonly report both and often do not include either in their reporting or analysis.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Collister D, Pyne L, Bhasin AA, et al. Sex and Gender in Randomized Controlled Trials of Adults Receiving Maintenance Dialysis: A Meta-epidemiologic Study. Am J Kidney Dis. 2022. PMID: 36535536. doi:10.1053/j.ajkd.2022.10.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。